Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1985-09-09
1988-07-26
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
558406, 558408, 560 55, 568441, A01K 31275, C07C12180
Patent
active
047600896
ABSTRACT:
Potent, irreversible dopamine-.beta.-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors or 2-cyano-2-phenethylamine, and methods of using these inhibitors or 2-cyano-2-phenethylamine to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.
REFERENCES:
Taguchi et al., "Chem. Pharm. Bult.", vol. 29, No. 1 (1981), pp. 55-62.
Eiden et al., Arch. Pharmaz., 306, pp. 470-475 (1973).
Eiden et al., Arch. Pharmaz., 304, pp. 628-633 (1971).
Temulis et al., Chem. Abstracts, vol. 85: 123138p (1976).
Chambers Pamela A.
Frazee James S.
Kaiser Carl
Kruse Lawrence I.
Fabiano Vincent L.
Lourie Alan D.
SmithKline Beckman Corporation
Suter Stuart R.
Sutto Anton H.
LandOfFree
Irreversible dopamine-.beta.-hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Irreversible dopamine-.beta.-hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Irreversible dopamine-.beta.-hydroxylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258234